Elisabeth G Klompenhouwer1, Adri C Voogd2, Gerard J den Heeten3, Luc J A Strobbe4, Anton F J de Haan5, Carla A Wauters5, Mireille J M Broeders6, Lucien E M Duijm7. 1. Department of Radiology, Catharina Hospital, PO Box 1350, 5602 ZA Eindhoven, The Netherlands. Electronic address: elisabethgenevieve@hotmail.com. 2. Comprehensive Cancer Centre South (IKZ)/Eindhoven Cancer Registry, PO Box 231, 5600 AE Eindhoven, The Netherlands; Department of Epidemiology, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. 3. National Expert and Training Centre for Breast Cancer Screening, PO Box 6873, 6503 GJ Nijmegen, The Netherlands. 4. Department of Surgical Oncology, Canisius Wilhelmina Hospital, PO Box 9015, 6500 GS Nijmegen, The Netherlands. 5. Department of Pathology, Canisius Wilhelmina Hospital, PO Box 9015, 6500 GS Nijmegen, The Netherlands. 6. National Expert and Training Centre for Breast Cancer Screening, PO Box 6873, 6503 GJ Nijmegen, The Netherlands; Department for Health Evidence, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. 7. Department of Radiology, Canisius Wilhelmina Hospital, PO Box 9015, 6500 GS Nijmegen, The Netherlands.
Abstract
PURPOSE: To prospectively determine the screening mammography outcome at blinded and non-blinded double reading in a biennial population based screening programme in the south of the Netherlands. METHODS: We included a consecutive series of 87,487 digital screening mammograms, obtained between July 2009 and July 2011. Screening mammograms were double read in either a blinded (2nd reader was not informed about the 1st reader's decision) or non-blinded fashion (2nd reader was informed about the 1st reader's decision). This reading strategy was alternated on a monthly basis. Women with discrepant readings between the two radiologists were always referred for further analysis. During 2 years follow-up, we collected the radiology reports, surgical correspondence and pathology reports of all referred women and interval breast cancers. RESULTS: Respectively 44,491 and 42,996 screens had been read either in a blinded or non-blinded fashion. Referral rate (3.3% versus 2.8%, p<0.001) and false positive rate (2.6% versus 2.2%, p=0.002) were significantly higher at blinded double reading whereas the cancer detection rate per 1000 screens (7.4 versus 6.5, p=0.14) and positive predictive value of referral (22% versus 23%, p=0.51) were comparable. Blinded double reading resulted in a significantly higher programme sensitivity (83% versus 76%, p=0.01). Per 1000 screened women, blinded double reading would yield 0.9 more screen detected cancers and 0.6 less interval cancers than non-blinded double reading, at the expense of 4.4 more recalls. CONCLUSION: We advocate the use of blinded double reading in order to achieve a better programme sensitivity, at the expense of an increased referral rate and false positive referral rate.
PURPOSE: To prospectively determine the screening mammography outcome at blinded and non-blinded double reading in a biennial population based screening programme in the south of the Netherlands. METHODS: We included a consecutive series of 87,487 digital screening mammograms, obtained between July 2009 and July 2011. Screening mammograms were double read in either a blinded (2nd reader was not informed about the 1st reader's decision) or non-blinded fashion (2nd reader was informed about the 1st reader's decision). This reading strategy was alternated on a monthly basis. Women with discrepant readings between the two radiologists were always referred for further analysis. During 2 years follow-up, we collected the radiology reports, surgical correspondence and pathology reports of all referred women and interval breast cancers. RESULTS: Respectively 44,491 and 42,996 screens had been read either in a blinded or non-blinded fashion. Referral rate (3.3% versus 2.8%, p<0.001) and false positive rate (2.6% versus 2.2%, p=0.002) were significantly higher at blinded double reading whereas the cancer detection rate per 1000 screens (7.4 versus 6.5, p=0.14) and positive predictive value of referral (22% versus 23%, p=0.51) were comparable. Blinded double reading resulted in a significantly higher programme sensitivity (83% versus 76%, p=0.01). Per 1000 screened women, blinded double reading would yield 0.9 more screen detected cancers and 0.6 less interval cancers than non-blinded double reading, at the expense of 4.4 more recalls. CONCLUSION: We advocate the use of blinded double reading in order to achieve a better programme sensitivity, at the expense of an increased referral rate and false positive referral rate.
Authors: Elisabeth G Klompenhouwer; Adri C Voogd; Gerard J den Heeten; Luc J A Strobbe; Vivianne C Tjan-Heijnen; Mireille J M Broeders; Lucien E M Duijm Journal: Eur Radiol Date: 2015-04-18 Impact factor: 5.315
Authors: Angela M P Coolen; Joost R C Lameijer; Adri C Voogd; Marieke W J Louwman; Luc J Strobbe; Vivianne C G Tjan-Heijnen; Lucien E M Duijm Journal: Eur Radiol Date: 2018-06-25 Impact factor: 5.315
Authors: Kathleen F Kerr; Gary M Longton; Lisa M Reisch; Andrea C Radick; Megan M Eguchi; Hannah L Shucard; Margaret S Pepe; Michael W Piepkorn; David E Elder; Raymond L Barnhill; Joann G Elmore Journal: Clin Exp Dermatol Date: 2022-06-22 Impact factor: 4.481
Authors: Jacky D Luiten; Bram Korte; Adri C Voogd; Willem Vreuls; Ernest J T Luiten; Luc J Strobbe; Matthieu J C M Rutten; Menno L Plaisier; Paul N Lohle; Marianne J H Hooijen; Vivianne C G Tjan-Heijnen; Lucien E M Duijm Journal: Int J Cancer Date: 2019-05-02 Impact factor: 7.396
Authors: Roy J P Weber; Elisabeth G Klompenhouwer; Adri C Voogd; Luc J A Strobbe; Mireille J M Broeders; Lucien E M Duijm Journal: Br J Cancer Date: 2015-08-18 Impact factor: 7.640
Authors: Khawaja Bilal Waheed; Muhammad Zia Ul Hassan; Donya Al Hassan; Alaa Ali Ghaithan Al Shamrani; Muneera Al Bassam; Ahmed Aly Elbyali; Tamer Mohamed Shams; Zainab Ahmed Demiati; Zechriah Jebakumar Arulanatham Journal: Ann Saudi Med Date: 2019-08-05 Impact factor: 1.526
Authors: Jennifer A Cooper; David Jenkinson; Chris Stinton; Matthew G Wallis; Sue Hudson; Sian Taylor-Phillips Journal: Eur Radiol Date: 2021-06-12 Impact factor: 5.315